1. Efficacy and safety of tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study;Afilalo;Clinical Drug Investigation,2010
2. Grünenthal GmbH A study to evaluate the efficacy and safety of cg5503 prolonged release (PR) in subjects with moderate to severe chronic pain due to osteoarthritis of the knee clinicaltrials.gov/show/NCT00486811
3. Kelly K Etropolski M Kuperwasser B Okamoto A Steup A vanHove I Similar analgesic effect and improved tolerability of tapentadol extended release versus oxycodone controlled release for the management of chronic osteoarthritis knee pain: results from a randomized, double-blind, phase3 trial Proceedings of the Annual EULAR Conference; 2009 Jun 10-13; Copenhagen, Denmark
4. Kelly K Lange B Etropolski M Kuperwasser B Okamoto A vanHove I Dose stability of tapentadol extended release (ER) for the relief of moderate-to-severe chronic osteoarthritic knee pain Proceedings of the 26th Annual Meeting of the American Academy of Pain Medicine; 2010 Feb 3-6; San Antonio, TX
5. Efficacy and safety of tapentadol prolonged release (PR) based on prior experience in patients with chronic osteoarthritis knee pain;Lange;Annals of Rheumatic Diseases,2010